Cellectis Reports Financial Results for First Quarter 2024
• Cellectis announced completion of the additional equity investment of $140M by AstraZeneca
Stay updated with breaking news from Marc Dunoyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
• Cellectis announced completion of the additional equity investment of $140M by AstraZeneca
. Cellectis announced completion of the additional equity investment of $140M by AstraZeneca . Cash position of $143 million as of March 31
Investor Day 2024 Unlocking growth to 2030 and beyond Speaker biographies Pascal Soriot ...
Completion of the additional equity investment of $140M by AstraZeneca, as previously announced on November 1 and 15, 2023 NEW YORK, May 06, 2024 -- Cellectis a clinical-stage biotechnology...
Cellectis said on Monday that AstraZeneca had finalized its additional $140 million investment in the company, in line with the deal announced last November.The biotech company, which specializes in...